Epidemiology of cutaneous T-cell lymphomas: state of the art and a focus on the Italian Marche region
Alessandro Pileri(Azienda USL di Bologna), Serena Rupoli(Marche Polytechnic University), Corrado Zengarini(Azienda USL di Bologna), Elena Torre(Ospedali Riuniti di Ancona), Stefano Pileri(European Institute of Oncology), Gaia Goteri(Marche Polytechnic University), Pietro Quaglino(Department of Medical Sciences), Erika Morsia(Marche Polytechnic University), Nicola Pimpinelli(University of Florence), Pier Luigi Zinzani(Istituto di Ematologia di Bologna), Marco Paulli(University of Milan)
Cited by 9
Related Papers
Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer
|Journal of Clinical Oncology|2011|657
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
|The Lancet|2017|580
Defining early mycosis fungoides
|Journal of the American Academy of Dermatology|2005|543
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
|Nature Medicine|2021|523